近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
1. Hu MY#, Zhang P#, Leng M, Li C, Chen L*. Animal-assisted intervention for individuals with cognitive impairment: a meta-analysis of randomized controlled trials and quasi-randomized controlled trials[J]. Psychiatry research, 2018, 260: 418-427.
2. Jia Yong, Li Feng, Liu Yufei, Zhao Jinping, Leng Minmin, Chen Li*. Depression and cancer risk: a systematic review and meta-analysis[J].Public health,2017 ,149:138-148.
3. Chen Li#, Duo Xu#, Mingyue Hu, Yongfei Tan, Ping Zhang, Guichen Li, Li Chen*. A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for patients with diabetes and depression[J]. Journal of Psychosomatic Research, 2017,95:44-54.
4. 李晨,白越,胡明月,陈立*.网络认知行为疗法在精神障碍患者中的研究现状[J].护理学杂志,2017, 32(11): 101-104.
5. 华珊珊,李闺臣,彩虹,刘宇飞,陈立*.运动疗法对糖尿病周围神经病变影响的研究进展[J].中华护理杂志,2017,52(10):1252-1256.
6. 华珊珊,陈立,彩虹,刘延迪,李菲*.2型糖尿病患者慢性甲醇中毒的护理[J].护理学杂志,2017,32(07):28-30.
7. Hong Cai#, Guichen Li#, Shanshan Hua, Yufei Liu, Li Chen*. Effect of exercise on cognitive function in chronic disease patients: a meta-analysis and systematic review of randomized controlled trials[J]. Clinical Interventions in Aging, 2017:12 773–783.
8. Hong Cai#, Guichen Li#, Ping Zhang, Duo Xu, Li Chen*. Effect of exercise on the quality of life in type 2 diabetes mellitus: a systematic review [J]. Quality of Life Research, 2017:26 .515-530.
9. Hu MY#, Zhang P#, Li C, Tan YY, Li GC, Xu D, Chen L *. Sleep disturbance in mild cognitive impairment: a systematic review of objective measures[J]. Neurological Sciences, 2017, 38(8): 1363-1371.
10. 胡明月#,张萍,李晨,华珊珊,彩虹,陈立*.轻度认知障碍患者体内微量元素Cu和Zn含量的Meta分析[J].现代预防医学, 2017,44(6):1097-1101.
11. 冷敏敏,张萍,胡明月,陈立*.玩偶疗法在痴呆患者护理中的应用进展[J].中华护理杂志, 2017, 52(11): 1322-1326.
12. 赵金萍,李晨,许多,陈立*.对癌症患者实施网络干预的研究进展[J].中华护理杂志,2017,52(11):1375-1378.
13. 华珊珊,陈立,李菲,彩虹,胡明月,李晨,李闺臣*.儿童饮水现状及脱水对其认知功能影响的研究进展[J].护理学杂志,2016,31(23):102-105.
14. Zhao Y, Cui L, Pan Y, Shao D, Zheng X, Zhang F, Zhang H, He K, Chen L. Berberine inhibits the chemotherapy-induced repopulation by suppressing the arachidonic acid metabolic pathway and phosphorylation of FAK in ovarian cancer.Cell Prolif. 2017 Dec;50(6).
15. Chang W(#), Zhang M, Chen L, Hatch GM*. Berberine Inhibits Oxygen Consumption Rate Independent of Alteration in Cardiolipin Levels in H9c2 Cells. Lipids. 2017 Sep 23. doi: 10.1007/s11745-017-4300-z.
16. Pan Y(#), Zhang F, Zhao Y, Shao D, Zheng X, Chen Y, He K, Li J, Chen L*. Berberine Enhances Chemosensitivity and Induces Apoptosis Through Dose-orchestrated AMPK Signaling in Breast Cancer. J Cancer. 2017 Jun 5;8(9):1679-1689.
17. Yu Y(#), Feng L, Li J, Lan X, A L, Lv X, Zhang M*, Chen L. The alteration of autophagy and apoptosis in the hippocampus of rats with natural aging-dependent cognitive deficits.Behav Brain Res. 2017 Sep 15;334:155-162.
18. Yao F(#), Chen L, Fan Z, Teng F, Zhao Y, Guan F, Zhang M*, Liu Y. Interplay between H6PDH and 11β-HSD1 implicated in the pathogenesis of type 2 diabetes mellitus.Bioorg Med Chem Lett. 2017 Sep 1;27(17):4107-4113.
19. Shao D, Lu M, Xu D, Zheng X, Pan Y, Song Y, Xu J, Li M, Zhang M, Li J, Chi G*, Chen L*, Yang B. Carbon dots for tracking and promoting the osteogenic differentiation of mesenchymal stem cells.Biomater Sci. 2017 Aug 22;5(9):1820-1827.
20. Pan Y, Shao D, Zhao Y, Zhang F, Zheng X, Tan Y, He K, Li J, Chen L*. Berberine Reverses Hypoxia-induced Chemoresistance in Breast Cancer through the Inhibition of AMPK- HIF-1α. Int J Biol Sci. 2017 Jun 1;13(6):794-803.
21. Yao F(#), Zhang M, Chen L*. Adipose Tissue-Specialized Immunologic Features Might Be the Potential Therapeutic Target of Prospective Medicines for Obesity. J Diabetes Res. 2017;2017:4504612.
22. Yao F(#), Yu Y, Feng L, Li J, Zhang M, Lan X, Yan X, Liu Y, Guan F, Zhang M*, Chen L*. Adipogenic miR-27a in adipose tissue upregulates macrophage activation via inhibiting PPARγof insulin resistance induced by high-fat diet-associated obesity. Exp Cell Res. 2017 Jun 15;355(2):105-112.
23. Shao D(#), Lu MM, Zhao YW, Zhang F, Tan YF, Zheng X, Pan Y, Xiao XA, Wang Z, Dong WF, Li J, Chen L. The shape effect of magnetic mesoporous silica nanoparticles on endocytosis, biocompatibility and biodistribution. Acta Biomater. 2017 Feb;49:531-540.
24. Jin Y, Liu S, Ma Q, Xiao D, Chen L*. Berberine enhances the AMPK activation and autophagy and mitigates high glucose-induced apoptosis of mouse podocytes. Eur J Pharmacol. 2017 Jan 5;794:106-114.
25. Wei S(#),, Zhang M(#), Yu Y, Xue H, Lan X, Liu S, Hatch G, Chen L*. HNF-4aregulated miR-122 contributes to development of gluconeogenesis and lipid metabolism disorders in Type 2 diabetic mice and in palmitate-treated HepG2 cells. Eur J Pharmacol. 2016 Nov 15;791:254-263.
26. Shao D(#),Li J(#), Zheng X, Pan Y, Wang Z, Zhang M, Chen QX, Dong WF, Chen L*. Janus "nano-bullets" for magnetic targeting liver cancer chemotherapy.Biomaterials. 2016 Sep;100:118-33.
27. Xue H(#), Ji Y(#), Wei S, Yu Y, Yan X, Liu S, Zhang M, Yao F, Lan X, Chen L*. HGSD attenuates neuronal apoptosis through enhancing neuronal autophagy in the brain of diabetic mice: The role of AMP-activated protein kinase. Life Sci. 2016 May 15;153:23-34.
28. Zhang M, Feng LJ, Li JN, Chen L*. Therapeutic Potential and Mechanisms of Berberine in Cardiovascular Disease. Curr Pharmacol Rep 2016;2:281-292.
29. Chen W(#),Wei S(#), Yu Y, Xue H, Yao F, Zhang M*, Xiao J*, Hatch GM, Chen L. Pretreatment of rats with increased bioavailable berberine attenuates cerebral ischemia-reperfusion injury via down regulation of adenosine-5'monophosphate kinase activity. Eur J Pharmacol. 2016 May 15;779:80-90.
30. Wei S(#), Zhang M(#), Yu Y, Lan X, Yao F, Yan X, Chen L*Hatch GM. Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4amiR122 Pathway.PLoS One. 2016 Mar 24;11(3):e0152097.
31. Yao F#, Zhang M, Chen L*. 5'-Monophosphate-activated protein kinase (AMPK) improves autophagic activity in diabetes and diabetic complications. Acta Pharm Sin B. 2016 Jan;6(1):20-5.
32. Chang W, Li K, Guan F, Yao F, Yu Y, Zhang M*, Hatch GM, Chen L.Berberine Pretreatment Confers Cardioprotection Against Ischemia-Reperfusion Injury in a Rat Model of Type 2 Diabetes.J Cardiovasc Pharmacol Ther. 2016 Feb 4.
33. Shao D, Wang Z, Dong WF, Zhang X, Zheng X, Xiao XA, Wang YS, Zhao X, Zhang M, Li J, Huo QS, Chen L. Facile Synthesis of Core-shell Magnetic Mesoporous Silica Nanoparticles for pH-sensitive Anticancer Drug Delivery. Chem Biol Drug Des. 2015 Dec;86(6):1548-53.
34. Xiao Zheng, Dan Shao, Jing Li, Yubin Song, Yujing Chen, Yue Pan, Shoujun Zhu, Bai Yang and Li Chen. Single and repeated dose toxicity of citric acid-based carbon dots and a derivative in mice. RSC Adv., 2015, 5, 91398-91406.
35. Chang W(#), Zhang M(#), Meng Z, Yu Y, Yao F, Hatch GM, Chen L*. Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5'-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells. Eur J Pharmacol. 2015 Dec 15;769:55-63.
36. Wei S, Li W, Yu Y, Yao F, A L, Lan X, Guan F, Zhang M*, Chen L*Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.Life Sci. 2015 Oct 15;139:8-15
37. Li J (#), Li O(#), Kan M, Zhang M, Shao D, Pan Y, Zheng H, Zhang X*, Chen L*, Liu S. Berberine induces apoptosis by suppressing the arachidonic acid metabolic pathway in hepatocellular carcinoma. Mol Med Rep. 2015 Sep;12(3):4572-7.
38. Dan Shao (#), Jing Li (#), Yue Pan, Xin Zhang, Xiao Zheng, Zheng Wang, Ming Zhang, Hong Zhang* and Li Chen* Noninvasive theranostic imaging of HSV-TK/GCV suicide gene therapy in liver cancer by folate targeted quantum dot-based liposomes. Biomater Sci. 2015 Jun 19;3(6):833-41.
39. Sun B, Li J(#), Shao D, Pan Y, Chen Y, Li S, Yao X, Li H, Liu W, Zhang M, Zhang X*, Chen L*. Adipose tissue-secreted miR-27a promotes liver cancer by targeting FOXO1 in obese individuals.Onco Targets Ther. 2015 Apr 7;8:735-44.
40. Yue Pan, Zheng Wang,Dan Shao, Huilin Zheng, Yujing Chen, Xiao Zheng, Ming Zhang,Jing Li,* Feng Li, Li Chen*. CTAB induced mitochondrial apoptosis by activating the AMPK–p53 pathway in hepatocarcinoma cells. Toxicol. Res. , 2015, 4,1359.
41. Li S, Li J, Fei BY, Shao D, Pan Y, Mo ZH, Sun BZ, Zhang D, Zheng X, Zhang M, Zhang XW, Chen L.MiR-27a Promotes Hepatocellular Carcinoma Cell Proliferation Through Suppression of its Target Gene Peroxisome Proliferator-activated Receptor γ.Chin Med J (Engl). 2015 5th Apr;128(7):941-947.